Pacira BioSciences, Inc.
PCRXNasdaqCIK 1396814HealthcareFiscal year ends Dec 31
Reports and events: 320 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1317:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-115589 |
| 2026-10-0809:24 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-114571 |
| 2026-08-0416:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-052635 |
| 2026-08-0416:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052527 |
| 2026-06-3007:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-046136 |
| 2026-06-1116:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-042525 |
| 2026-04-3016:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-028871 |
| 2026-04-3016:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-028854 |
| 2026-03-1219:57 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001011438-26-000180 |
| 2026-02-2616:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012297 |
| 2026-02-2616:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-012238 |
| 2026-01-2808:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-003717 |
| 2026-01-0816:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-001335 |
| 2026-01-0212:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-26-000011 |
| 2025-11-1020:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-016174 |
| 2025-11-0616:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-050176 |
| 2025-11-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-050145 |
| 2025-08-0813:26 ET | SCHEDULE 13D | Ownership report, active investor | 0001962221-25-000003 |
| 2025-08-0516:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001396814-25-000102 |
| 2025-08-0516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-25-000100 |
| 2025-07-1007:35 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-25-000093 |
| 2025-07-0708:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-065979 |
| 2025-06-1316:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001396814-25-000089 |
| 2025-05-0816:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001396814-25-000061 |
| 2025-05-0816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-25-000060 |
| 2025-04-2916:08 ET | DEF 14A | Proxy statementPeriod 2024-06-10 | 0001104659-25-041219 |
| 2025-04-2208:59 ET | 8-K | 8.01 Other events | 0001396814-25-000055 |
| 2025-04-0716:59 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-25-000051 |
| 2025-03-1417:28 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001396814-25-000048 |
| 2025-02-2716:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001396814-25-000041 |
| 2025-02-2716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-25-000039 |
| 2025-01-3008:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-25-000022 |
| 2025-01-2108:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-25-000017 |
| 2025-01-1008:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-25-000011 |
| 2024-11-0616:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001396814-24-000141 |
| 2024-11-0616:00 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001396814-24-000140 |
| 2024-10-2108:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-24-000129 |
| 2024-09-2708:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001396814-24-000124 |
| 2024-09-0916:02 ET | 8-K | 8.01 Other events | 0001396814-24-000120 |
| 2024-08-0915:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001396814-24-000103 |
| 2024-07-3016:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001396814-24-000098 |
| 2024-07-3016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-24-000097 |
| 2024-06-1317:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001396814-24-000057 |
| 2024-05-1416:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-061135 |
| 2024-05-0816:13 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-058675 |
| 2024-05-0716:02 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001396814-24-000045 |
| 2024-05-0716:01 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001396814-24-000044 |
| 2024-04-2216:16 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001104659-24-049997 |
| 2024-02-2915:33 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001396814-24-000030 |
| 2024-02-2908:03 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-24-000026 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:40 ET. Listed shows no prices and gives no investment advice.